Biobot Analytics Competitors

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Maple Leaf Foods is Canada’s leading consumer-packaged protein company, headquartered in Mississauga, Ontario. We make high-quality, great tasting, nutritious and innovative food products under leading brands including Maple Leaf®, Schneiders®, Mina®, Greenfield Natural Meat Co.®, Fantino and Mondello, Lunch Mate™, Grab'N Snack™, Field Roast™, and LightLife®. Maple Leaf Foods employs approximately 13,500 people and does business in Canada, U.S. and Asia. Our people are passionate about their work and the products they make. Our vision is to be the most sustainable protein company on earth. This deeply held commitment guides all our decisions. We strive to make our Maple Leaf Foods LinkedIn account an acceptable and welcoming place for all, and promote a positive and pleasant experience online. For more information, please read our Social Media House Rules: https://ow.ly/uhzV50PlIRz -- Les Aliments Maple Leaf est une société canadienne chef de file du secteur des viandes de consommation emballées dont le siège social est situé à Mississauga, en Ontario. Nous fabriquons des produits savoureux, nutritifs et novateurs de qualité supérieure commercialisés sous des marques nationales comme Maple Leaf®, Schneiders®, MinaMD, Greenfield Natural Meat Co.MD, Fantino and Mondello, Lunch MateMC, Grab'N SnackMC, Field RoastMC et LightLife®. Les Aliments Maple Leaf emploie environ 13 500 personnes et exerce ses activités au Canada, aux États Unis et en Asie. Notre vision est d’être l’entreprise de produits de protéines la plus durable sur terre. Cet engagement profond guide toutes nos décisions. Nous nous efforçons de rendre notre compte LinkedIn des Aliments Maple Leaf un endroit acceptable et accueillant pour tous et d’y offrir une expérience positive et agréable en ligne. Pour obtenir de plus amples renseignements, veuillez lire notre règlement interne relatif aux médias sociaux : https://ow.ly/1EWb50Q1HEB

Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.